| Structure | Chemical Name | CAS | MF |
|
2-ACETAMIDO-4-CHLORO-5-METHYLPHENOL
|
153506-14-0
|
C9H10ClNO2
|
|
0.05 MOL IODINE (I2) FIXANAL (IODATE)
|
153507-24-5
|
I3K
|
|
Bibapcitide
|
153507-46-1
|
C112H162N36O43S10
|
|
2(1H)-Pyridinethione,6-methoxy-(9CI)
|
153508-43-1
|
C6H7NOS
|
|
H-D-ALA-GLN-OCTADECYL ESTER HCL
|
153508-74-8
|
C18H36ClN3O4
|
|
AMINO-MODIFIER-C 2-DT CEP
|
153512-22-2
|
C46H54F3N6O10P
|
|
5'-O-(DIMETHOXYTRITYL)-5-[N-(2-(TRIFLUOROACETAMIDO)ETHYL)-3-(E)-ACRYLAMIDO]-2'-DEOXYURIDINE
|
153512-23-3
|
C37H37F3N4O9
|
|
H-PHE-ARG-ALA-ASP-HIS-PRO-PHE-LEU-OH ACETATE SALT
|
153512-29-9
|
C48H67N13O11
|
|
biotin-phenylalanyl-(S-benzyl)cysteinyl-diazomethane
|
153512-31-3
|
C30H36N6O4S2
|
|
4-(2-CHLOROPHENYL)SEMICARBAZIDE HYDROCHLORIDE
|
153513-57-6
|
C7H9Cl2N3O
|
|
4-[3-(TRIFLUOROMETHYL)PHENYL]SEMICARBAZIDE HYDROCHLORIDE
|
153513-69-0
|
C8H9ClF3N3O
|
|
L-Alanine, N-[[3-(aminocarbonyl)oxiranyl]carbonyl]-, (2R-trans)- (9CI)
|
153513-93-0
|
C7H10N2O5
|
|
3,5-Dimethyl-1H-pyrazole reaction products with 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane trimer
|
153519-41-6
|
|
|
|
BLOCKED HEXAMETHYLENE DIISOCYANATE POLYMER)
|
153519-43-8
|
|
|
UV Absorber 400
|
153519-44-9
|
C81H108N6O8
|
|
2,3,7-/2,3,8-TRIMETHYLDIBENZOTHIOPHENE
|
153524-16-4
|
C15H14S
|
|
ETHYL (S)-3-(3-PYRIDYL)-BETA-ALANATE DIHYDROCHLORIDE
|
153524-69-7
|
C10H15ClN2O2
|
|
N-DesMethyl Eletriptan
|
153525-55-4
|
C21H24N2O2S
|
|
4-(3-(1,2-dihydro-6-methoxynaphthalen-4-yl)-n-propyl)-1-(2-methoxyphenyl)piperazine
|
153526-61-5
|
C25H32N2O2
|
|
4-(3-(1,2-dihydro-8-methoxynaphthalen-4-yl)-n-propyl)-1-(2-pyridyl)piperazine
|
153526-67-1
|
C25H32N2O2
|
|
2-(3-Fluorophenyl)-1-(4-Methoxyphenyl)ethanone
|
153529-18-1
|
C15H13FO2
|
|
2-(2,4-Dichlorophenyl)-1-(4-Methoxyphenyl)ethanone
|
153529-19-2
|
C15H12Cl2O2
|
|
4-Hydroxy-L-hoMoserine Trifluoroacetic Acid Salt
|
153530-52-0
|
C6H10F3NO6
|
|
3-dodecanoyl-4-phosphatidylcholinohydroxymethyl-2-oxazolidinone
|
153531-48-7
|
C21H41N2O7P
|
|
TRI-MAGNESIUM DICITRATE NONAHYDRATE
|
153531-96-5
|
C12H28Mg3O23
|
|
1,2,3-Propanetricarboxylic acid, 2-hydroxy-, iron(3+) salt (1:1), monohydrate
|
153531-98-7
|
C6H10FeO8
|
|
TRANS-1,1,1-TRIFLUORO-4-(3-INDOLYL)-3-BUTEN-2-ONE
|
153532-01-5
|
C12H8F3NO
|
|
N-(1-PYRENEMETHYL)IODOACETAMIDE
|
153534-76-0
|
C19H14INO
|
|
Cyclopropanecarboxylic acid, 1-amino-2-(2-hydroxyethyl)- (9CI)
|
153536-18-6
|
C6H11NO3
|
|
Nicotine N-β-D-Glucuronide
|
153536-53-9
|
C16H22N2O7
|
|
Plevitrexed
|
153537-73-6
|
C26H25FN8O4
|
|
PLEVITREXED
|
153538-08-0
|
C26H25FN8O4
|
|
Hydrazinecarboxamide, N-4-pyridinyl-
|
153539-26-5
|
C6H8N4O
|
|
BIS(ISOBUTYLCYCLOPENTADIENYL)ZIRCONIUM DICHLORIDE
|
153539-81-2
|
C18H26Cl2Zr10*
|
|
2,5-Piperazinedithione,3,6-dimethyl-,trans-(9CI)
|
153545-23-4
|
C6H10N2S2
|
|
7β,17α-Dimethyl-5β-androstane-3α,17β-diol
|
153546-23-7
|
C21H36O2
|
|
4-Oxazolidinecarboxylicacid,5-methyl-2-oxo-,methylester,(4S,5R)-(9CI)
|
153547-44-5
|
C6H9NO4
|
|
(D-TRP32)-NEUROPEPTIDE Y (HUMAN, RAT)
|
153549-78-1
|
C197H290N56O56
|
|
D-Trp(34) neuropeptide Y
|
153549-84-9
|
C196H289N55O56
|
|
|
amberlite irc76 hydrogen form
|
153550-33-5
|
|
|
|
AMERCHOLL500
|
153550-36-8
|
|
|
|
Ustilago maydis viral toxin KP4
|
153552-15-9
|
|
|
|
integrin betanu
|
153552-93-3
|
|
|
|
CpxR protein
|
153554-07-5
|
|
|
4-Bromo-3-fluorobenzoic acid
|
153556-42-4
|
C7H4BrFO2
|
|
Methyl 2-fluoro-6-trifluoroMethylbenzoate
|
153556-50-4
|
C9H6F4O2
|
|
4-bromo-2,5-dimethoxybenzene-1-sulfonyl chloride
|
153556-55-9
|
C8H6ClFO2
|
|
1-Aziridinecarboxamide,2-methyl-N-(1-methylethyl)-(9CI)
|
153556-76-4
|
C7H14N2O
|
|
Piperidine, 1-(1-iminoethyl)- (9CI)
|
153558-50-0
|
C7H14N2
|
|
Morpholine, 4-(1-iminoethyl)- (9CI)
|
153558-51-1
|
C6H12N2O
|
|
4-Pyridinecarboxylicacid,2-(chlorocarbonyl)-,methylester(9CI)
|
153559-43-4
|
C8H6ClNO3
|
|
6-[(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethenyl]nicotinic Acid Methyl Ester
|
153559-44-5
|
C24H29NO2
|
|
Methyl 4-[(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)carbonyl]benzoate
|
153559-45-6
|
C24H28O3
|
|
4-[(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)carbonyl]benzoic acid
|
153559-46-7
|
C23H26O3
|
|
Benzoic acid, 4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]-, methyl ester
|
153559-48-9
|
C25H30O2
|
|
Bexarotene
|
153559-49-0
|
C24H28O2
|
|
METHYL 6-(1-(1,2,3,4-TETRAHYDRO-1,1,4,4,6-PENTAMETHYLNAPHTHALEN-7-YL)CYCLOPROPYL)PYRIDINE-3-CARBOXYLATE
|
153559-50-3
|
C25H31NO2
|
|
6-[1-(3,5,5,8,8-PENTAMETHYL-5,6,7,8-TETRAHYDRO-NAPHTHALEN-2-YL)-CYCLOPROPYL]-NICOTINIC ACID
|
153559-76-3
|
C24H29NO2
|
|
6-(3,5,5,8,8-PENTAMETHYL-5,6,7,8-TETRAHYDRO-NAPHTHALENE-2-CARBONYL)-NICOTINIC ACID METHYL ESTER
|
153559-92-3
|
C23H27NO3
|
|
Methyl 6-acetylnicotinate
|
153559-93-4
|
C9H9NO3
|
|
(5-Butylthiophen-2-yl)methanol
|
153561-68-3
|
C9H14OS
|
|
2-Bromo-5-dodecylthiophene
|
153561-74-1
|
C16H27BrS
|
|
5,5'''-Didodecyl-2,2':5',2'':5'',2'''-quaterthiophene
|
153561-79-6
|
C40H58S4
|
|
2-methoxy-5-nitrophenyl glycinate
|
153562-56-2
|
|
|
2-(Piperidin-4-yl)acetonitrile, hydrochloride
|
153566-98-4
|
C7H13ClN2
|
|
17-cyclopropylmethyl-4,5-epoxy-3,14-dihydroxymorphinan-6-one-7-spiro-2'-indan
|
153567-07-8
|
C28H29NO4
|
|
17-(cyclopropylmethyl)-7-benzyl-4,5-epoxy-3,14-dihydroxymorphinan-6-one
|
153567-11-4
|
C27H29NO4
|
|
3-fluoromethyl-1-(1-(2-benzothienyl)cyclohexyl)piperidine
|
153567-18-1
|
C20H26FNS
|
|
AKOS B018375
|
153567-96-5
|
C12H11NOS2
|
|
AKOS B018352
|
153567-97-6
|
C13H13NOS2
|
|
AKOS B018372
|
153568-04-8
|
C11H6F3NOS2
|
|
BOC-VAL-OH-2,3,4,4,4,5,5,5-D8
|
153568-33-3
|
C10H11D8NO4
|
|
Benzenemethanaminium, N,N-dimethyl-N-2-(1-oxo-2-propenyl)oxyethyl-, chloride, polymer with N,N-dimethyl-N-2-propenyl-2-propen-1-aminium chloride
|
153568-80-0
|
C22H36Cl2N2O2
|
|
5,6-DIMETHOXY-2-(DI-N-PROPYLAMINO)INDAN MALEATE
|
153570-58-2
|
C21H31NO6
|
|
|
LYCP-A precursor protein
|
153571-56-3
|
|
|
Carbamic acid, (dihydro-4,4-dimethyl-2-oxo-3(2H)-furanylidene)-, methyl ester (9CI)
|
153575-93-0
|
C8H11NO4
|
|
3-Thiophenamine,2-propyl-(9CI)
|
153576-31-9
|
C7H11NS
|
|
1-Cyclopentene-1-carboxylicacid,5,5-dimethyl-,methylester(9CI)
|
153580-04-2
|
C9H14O2
|
|
7-Oxa-1,2-diazaspiro[4.4]non-1-en-6-one,4-methyl-,cis-(9CI)
|
153580-05-3
|
C7H10N2O2
|
|
7-Oxa-1,2-diazaspiro[4.4]non-1-en-6-one,4-methyl-,trans-(9CI)
|
153580-06-4
|
C7H10N2O2
|
|
Cyclopentanecarboxamide, 2,2-dimethyl- (9CI)
|
153580-07-5
|
C8H15NO
|
|
DECYL ALCOHOL-1-14C
|
153584-66-8
|
C10H22O
|
|
2,4-DIFLUOROPHENYL CHLOROTHIOFORMATE
|
153585-18-3
|
C7H3ClF2OS
|
|
formyl-methylhomoseryl-leucyl-phenylalanine methyl ester
|
153586-91-5
|
C22H33N3O6
|
|
H-THR-GLU-PRO-GLU-TYR(PO3H2)-GLN-PRO-GLY-GLU-NH2
|
153586-97-1
|
C45H66N11O21P
|
|
NS 1619
|
153587-01-0
|
C15H8F6N2O2
|
|
3-(DIFLUOROMETHOXY)-4-METHOXYBENZALDEHYDE
|
153587-11-2
|
C9H8F2O3
|
|
3-Cyclopentyloxy-4-difluoromethoxy-benzaldehyde
|
153587-14-5
|
C13H14F2O3
|
|
Zirconium, 2,2-bis(2-propenyloxy-.kappa.O)methyl-1-butanolato-.kappa.Otris(2-methyl-2-propenoato-.kappa.O)-, (OC-6-22)-
|
153590-16-0
|
C24H36O9Zr
|
|
|
neutrophil inhibitory factor
|
153591-89-0
|
|
|
5-(1H-indol-3-ylmethyl)-4-phenyl-2,4-dihydro-3H-1,2,4-triazole-3-thione
|
153595-92-7
|
C17H14N4S
|
|
5-(1H-indol-3-ylmethyl)-1,3,4-Thiadiazol-2-amine
|
153595-93-8
|
C11H10N4S
|
|
1,2,5-Oxadiazole-3-carboxylicacid,4-[(2-aminoethyl)amino]-(9CI)
|
153596-02-2
|
C5H8N4O3
|
|
ETHYL 6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZINE-2-CARBOXYLATE
|
153597-59-2
|
C9H12N2O3
|
|
Benzoic acid, 3-(2-hydroxyethyl)-, methyl ester
|
153599-45-2
|
C10H12O3
|
|
2,4-Dichloro-5-trichloromethylpyrimidine
|
153600-16-9
|
C5HCl5N2
|
|
1H-Pyrrole-2-acetic acid, 3-formyl- (9CI)
|
153602-57-4
|
C7H7NO3
|
|
1H-Pyrrole-2-acetic acid, 3-acetyl- (9CI)
|
153602-58-5
|
C8H9NO3
|
|
5-ETHYL 1-ISOBUTYL 6-(TRIMETHYLSILYL)INDOLE-1,5-DICARBOXYLATE
|
153602-84-7
|
C19H27NO4Si
|
|
BETA-GLCNAC-[1->2]-ALPHA-MAN-[1->3][BETA-GLCNAC-(1->2)-ALPHA-MAN-(1->6)]-MAN
|
153604-55-8
|
C34H58N2O26
|